145 related articles for article (PubMed ID: 33407054)
1. Treatment of superficial vein thrombosis with intermediate dose of tinzaparin: A real word cohort study - The SeVEN EXTension study.
Karathanos C; Chatzis D; Latzios P; Papakostas I; Goumas K; Giannoukas AD;
Phlebology; 2021 Jul; 36(6):423-431. PubMed ID: 33407054
[TBL] [Abstract][Full Text] [Related]
2. Risk of recurrent thromboembolic events according to treatment duration in patients with superficial vein thrombosis treated with intermediate dose of tinzaparin.
Karathanos C; Kakkos SK; Georgiadis G; Ioannou C; Vasdekis S; Chatzis D; Latzios P; Giannoukas AD;
Phlebology; 2023 Apr; 38(3):141-149. PubMed ID: 36461172
[TBL] [Abstract][Full Text] [Related]
3. Tinzaparin in intermediate dose for the treatment of superficial vein thrombosis: Results from an observational multicenter study-SeVEN study.
Giannoukas A; Karathanos C; Nikolakopoulos K; Georgiadis GS; Maltezos C; Ioannou C; Vasdekis S; Trelopoulos G;
Phlebology; 2018 Oct; 33(9):636-645. PubMed ID: 29277133
[TBL] [Abstract][Full Text] [Related]
4. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
[TBL] [Abstract][Full Text] [Related]
5. Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT).
Bauersachs R; Gerlach HE; Heinken A; Hoffmann U; Langer F; Noppeney T; Pittrow D; Klotsche J; Rabe E
Eur J Vasc Endovasc Surg; 2021 Aug; 62(2):241-249. PubMed ID: 34210599
[TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum).
Cosmi B; Filippini M; Tonti D; Avruscio G; Ghirarduzzi A; Bucherini E; Camporese G; Imberti D; Palareti G;
J Thromb Haemost; 2012 Jun; 10(6):1026-35. PubMed ID: 22487001
[TBL] [Abstract][Full Text] [Related]
7. Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin.
Hyers TM; Spyropoulos AC;
J Thromb Thrombolysis; 2007 Dec; 24(3):225-32. PubMed ID: 17334932
[TBL] [Abstract][Full Text] [Related]
8. Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis.
Dager WE; King JH; Branch JM; Chow SL; Ferrer RE; Pak S; Togioka PY; White RH
Ann Pharmacother; 2005; 39(7-8):1182-7. PubMed ID: 15956232
[TBL] [Abstract][Full Text] [Related]
9. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial.
Daskalopoulos ME; Daskalopoulou SS; Tzortzis E; Sfiridis P; Nikolaou A; Dimitroulis D; Kakissis I; Liapis CD
Eur J Vasc Endovasc Surg; 2005 Jun; 29(6):638-50. PubMed ID: 15878544
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum).
Cosmi B; Filippini M; Campana F; Avruscio G; Ghirarduzzi A; Bucherini E; Camporese G; Imberti D; Legnani C; Palareti G;
Thromb Res; 2014 Feb; 133(2):196-202. PubMed ID: 24365043
[TBL] [Abstract][Full Text] [Related]
12. Tinzaparin in the treatment of venous thromboembolism.
Pineo GF; Hull RD
Expert Opin Pharmacother; 2003 Dec; 4(12):2355-62. PubMed ID: 14640933
[TBL] [Abstract][Full Text] [Related]
13. Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: the Innohep® in Renal Insufficiency Study (IRIS).
Leizorovicz A; Siguret V; Mottier D; ; Leizorovicz A; Siguret V; Mottier D; Clonier F; Janas M; Stinson J; Townshend G; Maddalena M
Thromb Res; 2011 Jul; 128(1):27-34. PubMed ID: 21477846
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy.
Ní Ainle F; Wong A; Appleby N; Byrne B; Regan C; Hassan T; Milner M; Sullivan AO; White B; O'Donnell J
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):689-92. PubMed ID: 18832911
[TBL] [Abstract][Full Text] [Related]
15. Extended-Duration Treatment of Superficial Vein Thrombosis of the Lower Limbs with Tinzaparin.
Nikolakopoulos KM; Kakkos SK; Papageorgopoulou CP; Tsolakis IA
Vasc Specialist Int; 2018 Mar; 34(1):1-9. PubMed ID: 29629359
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism.
Wells PS; Anderson DR; Rodger MA; Forgie MA; Florack P; Touchie D; Morrow B; Gray L; O'Rourke K; Wells G; Kovacs J; Kovacs MJ
Arch Intern Med; 2005 Apr; 165(7):733-8. PubMed ID: 15824291
[TBL] [Abstract][Full Text] [Related]
17. Urgent surgery versus anticoagulation for treatment of superficial vein thrombosis in patients with varicose veins.
Casian D; Bzovii F; Culiuc V; Gutu E
Vasa; 2022 May; 51(3):174-181. PubMed ID: 35418255
[No Abstract] [Full Text] [Related]
18. The incidence of heparin-induced thrombocytopenia in patients treated with low molecular weight heparin for superficial vein thrombosis.
Sartori M; Favaretto E; Migliaccio L; Guazzaloca G; Legnani C; Palareti G; Cosmi B
Thromb Res; 2016 Mar; 139():154-7. PubMed ID: 26916314
[TBL] [Abstract][Full Text] [Related]
19. Tinzaparin sodium: a low-molecular-weight heparin.
Neely JL; Carlson SS; Lenhart SE
Am J Health Syst Pharm; 2002 Aug; 59(15):1426-36. PubMed ID: 12166042
[TBL] [Abstract][Full Text] [Related]
20. Impact of emergency department management of isolated superficial vein thrombosis of the lower limbs: a secondary analysis of data from the ALTAMIRA study.
Beddar Chaib F; Jiménez Hernández S; Pedrajas Navas JM; Lecumberri R; Guirado Torrecillas L; Alonso Valle H; Diego Roza S; Sendín Martín V; Rivera Núñez MA; Pedraza García J; Sánchez Díaz-Canel D; Ruiz Artacho P;
Emergencias; 2023 Apr; 35(2):109-116. PubMed ID: 37038941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
